La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « trial »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
triads < trial < trials  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000017 (2013) Anthony E. Lang [Canada] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Olivier Rascol [France]Trial designs used to study neuroprotective therapy in Parkinson's disease
000164 (2012) A. Marquet [Suisse] ; K. Kupas [Allemagne] ; A. Johne [Allemagne] ; B. Astruc [France] ; A. Patat [France] ; S. Krösser [Allemagne] ; A. Kovar [Allemagne]The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double‐Blind, Clinical Trial
000303 (2011) Jean-Christophe Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier-Beaupel [France] ; Anne-Marie Bonnet [France] ; Marie-Hélène Fiévet [France] ; Agnès Bellanger [France] ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; Mouna Ben Djebara [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean-Sébastien Hulot [France] ; Marie Vidailhet [France]The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
000866 (2007) Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne]Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial
000963 (2006) Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
000A14 (2006) Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
001146 (2000) J. De Seze [France] ; G. Edan [France] ; M. Labalette [France] ; J. P. Dessaint [France] ; P. Vermersch [France]Effect of glatiramer acetate (Copaxone) given orally in human patients: Interleukin‐10 production during a phase 1 trial
001160 (2000) G. Geraud [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; J. Olesen [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; V. Pfaffenrath [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; P. Tfelt-Hansen [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; R. Zupping [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; H-C Diener [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; R. Sweet [France, Danemark, Allemagne, Estonie, Royaume-Uni]Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial Design
001644 (1997) Stephen D. White ; Patrick B. Bordeau ; Philippe Blumstein ; Catherine Ibisch ; Eric Guaguère ; Philippe Denerolle ; Didier N. Carlotti ; Katherine V. Scott [États-Unis]Feline acne and results of treatment with mupirocin in an open clinical trial: 25 cases (1994–96)
001D65 (1991) H. Allain [France] ; J. Cougnard [France] ; H-C. Neukirch [France]Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT)
001D70 (1991) Albert Faradji [France] ; Alain Bohbot [France] ; Marion Schmitt-Goguel [France] ; Norbert Roeslin [France] ; Serge Dumont [France] ; Marie-Louise Wiesel [France] ; Christian Lallot [France] ; Michel Eber [France] ; Jacques Bartholeyns [France] ; Philippe Poindron [France] ; Georges Morand [France] ; Jean-Paul Witz [France] ; Francis Oberling [France]Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effects
001F57 (1989) J. Arnaud [France] ; J. Buyse [Belgique] ; B. Nordlinger [France] ; F. Martin [France] ; J. Pector [Belgique] ; P. Zeitoun [France] ; A. Adloff [France] ; N. Duez [Belgique]Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double‐blind randomized clinical trial
002009 (1988) H. Allain ; J. Denmat ; D. Bentue-Ferrer [France] ; D. Milon [France] ; P. Pignol ; J. M. Reymann [France] ; D. Pape [France] ; O. Sabouraud ; J. Van Den Driessche [France]RANDOMIZED, DOUBLE‐BLIND TRIAL OF EXIFONE VERSUS COGNITIVE PROBLEMS IN PARKINSON'S DISEASE

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "trial" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "trial" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    trial
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024